new glp 1 drugs in development 9 Companies Developing Next-Generation GLP-1 GLP-1 Drugs Market Size to

Key features include: Once-daily dosing of 1.28 mg Concentrated for small daily injection volumes (0.16 mL) Stored at room temperature (no refrigeration required before or after reconstitution) Comes with BD SafetyGlide TM syringes for injection (with needle attached) (orange cap) EGRIFTA WR TM was designed for simpler daily administration , thereby reducing the burden of treatment

Rachmilewitz, D

However, individual responses vary significantly

In dendrites of cortical pyramidal neurons lacking a novel MAM protein PDZ domain-containing protein 8, a significant fraction of Ca 2+ released from the ER during synaptic stimulation accumulates in the cytosol and elevates the local dendritic Ca 2+ levels